Socio-economic burden of rare diseases: A systematic review of cost of illness evidence

2014/12/30 by Aris Angelis, David Tordrup, Panos Kanavos · 2 citations
Biochemistry, Genetics and Molecular Biology · Medicine · Neuroscience · #Autism Spectrum Disorder Research #Genetics and Neurodevelopmental Disorders #Neurogenetic and Muscular Disorders Research

paper · doi:10.1016/j.healthpol.2014.12.016

openalex publication_date 2014/12/30 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/28

Cited by

• Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects
• CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine